Van Campen Liem assisted uniQure N.V. (Nasdaq: QURE)
Van Campen Liem assisted uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, with the Dutch
Van Campen Liem assisted uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, with the Dutch
Van Campen Liem advised Enfinity Global Inc., a leader in renewable energy, on the Dutch aspects of a €500 million debt financing to build, own,
Van Campen Liem Advocaten en Notarissen feliciteert De Vrije Blick met de toekenning door de AFM van haar AIFMD-vergunning voor het mogen beheren en aanbieden
Mega Round This latest funding round was led by the International Finance Corporation (IFC) and saw participation from Development Partners International (DPI), Lorax Capital Partners,
BrightCap Ventures has completed the first close of its new fund targeting €60 million. The new capital will be invested in founders from Rising Southeastern
Van Campen Liem is pleased to have assisted Trilantic Europe as Luxembourg counsel in the acquisition of a majority stake in Aerocompact Group, a leading
Van Campen Liem is honored to have assisted PeakBridge as lead fund counsel in the context of the formation and successful closing of the PeakBridge
The financing is being provided by Canada Pension Plan Investment Board (CPP Investments) through subsidiaries of CPPIB Credit Investments Inc. The team at Van Campen
GapMinder Fund II is an investment vehicle with a target of €80 million, representing the largest VC with a primary focus on the Romanian tech
Van Campen Liem assisted GapMinder VC with the launch of GapMinder Fund II GapMinder Fund II is an investment vehicle with a target of €80 million, representing the largest